272 related articles for article (PubMed ID: 1716536)
1. Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin.
Lilja H; Christensson A; Dahlén U; Matikainen MT; Nilsson O; Pettersson K; Lövgren T
Clin Chem; 1991 Sep; 37(9):1618-25. PubMed ID: 1716536
[TBL] [Abstract][Full Text] [Related]
2. Serum prostate specific antigen complexed to alpha 1-antichymotrypsin as an indicator of prostate cancer.
Christensson A; Björk T; Nilsson O; Dahlén U; Matikainen MT; Cockett AT; Abrahamsson PA; Lilja H
J Urol; 1993 Jul; 150(1):100-5. PubMed ID: 7685416
[TBL] [Abstract][Full Text] [Related]
3. Prostate specific antigen predominantly forms a complex with alpha 1-antichymotrypsin in blood. Implications for procedures to measure prostate specific antigen in serum.
Lilja H; Cockett AT; Abrahamsson PA
Cancer; 1992 Jul; 70(1 Suppl):230-4. PubMed ID: 1376193
[TBL] [Abstract][Full Text] [Related]
4. A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer.
Stenman UH; Leinonen J; Alfthan H; Rannikko S; Tuhkanen K; Alfthan O
Cancer Res; 1991 Jan; 51(1):222-6. PubMed ID: 1703033
[TBL] [Abstract][Full Text] [Related]
5. Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors.
Christensson A; Laurell CB; Lilja H
Eur J Biochem; 1990 Dec; 194(3):755-63. PubMed ID: 1702714
[TBL] [Abstract][Full Text] [Related]
6. Characterization of epitope structure for 53 monoclonal antibodies against prostate-specific antigen.
Becker C; Wigheden I; Lilja H
Tumour Biol; 1999; 20 Suppl 1():13-7. PubMed ID: 10628403
[TBL] [Abstract][Full Text] [Related]
7. Addition of purified prostate specific antigen to serum from female subjects: studies on the relative inhibition by alpha 2-macroglobulin and alpha 1-antichymotrypsin.
Chen Z; Komatsu K; Prestigiacomo A; Stamey TA
J Urol; 1996 Oct; 156(4):1357-63. PubMed ID: 8808871
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies 2F5 and 4G10 against prostate specific antigen (PSA) complexed to alpha1-antichymotrypsin.
Chen Z; Chen H; Stamey TA
J Urol; 1998 Sep; 160(3 Pt 1):870-5. PubMed ID: 9720579
[TBL] [Abstract][Full Text] [Related]
9. Analysis of free prostate-specific antigen (PSA) after chemical release from the complex with alpha(1)-antichymotrypsin (PSA-ACT).
Peter J; Unverzagt C; Hoesel W
Clin Chem; 2000 Apr; 46(4):474-82. PubMed ID: 10759471
[TBL] [Abstract][Full Text] [Related]
10. Three immunoassays based on monoclonal antibodies specific for prostate specific antigen (PSA), alpha-1-antichymotrypsin (ACT), and the PSA-ACT complex.
Wan XS; Xu YA; Ware JH; Kennedy AR
Prostate; 2003 Jul; 56(2):131-41. PubMed ID: 12746838
[TBL] [Abstract][Full Text] [Related]
11. ELISA for a complexed antigen with a monoclonal antibody blocking reaction with the free antigen-assay-specific for complexed prostate-specific antigen.
Matsumoto K; Konishi N; Samori T; Kimura E; Doi M; Kato S; Yuki Y
J Immunol Methods; 2000 Feb; 234(1-2):99-106. PubMed ID: 10669774
[TBL] [Abstract][Full Text] [Related]
12. Multiple forms of prostate-specific antigen in serum: differences in immunorecognition by monoclonal and polyclonal assays.
Zhou AM; Tewari PC; Bluestein BI; Caldwell GW; Larsen FL
Clin Chem; 1993 Dec; 39(12):2483-91. PubMed ID: 7504592
[TBL] [Abstract][Full Text] [Related]
13. Prostate specific antigen complexed to alpha-1-antichymotrypsin in patients with intermediate prostate specific antigen levels.
Saika T; Tsushima T; Nasu Y; Kusaka N; Miyaji Y; Takamoto H; Takeda K; Uno S; Kumon H;
Cancer; 2002 Mar; 94(6):1685-91. PubMed ID: 11920529
[TBL] [Abstract][Full Text] [Related]
14. Free and complexed prostate-specific antigen (PSA): in vitro stability, epitope map, and development of immunofluorometric assays for specific and sensitive detection of free PSA and PSA-alpha 1-antichymotrypsin complex.
Pettersson K; Piironen T; Seppälä M; Liukkonen L; Christensson A; Matikainen MT; Suonpää M; Lövgren T; Lilja H
Clin Chem; 1995 Oct; 41(10):1480-8. PubMed ID: 7586521
[TBL] [Abstract][Full Text] [Related]
15. The establishment and evaluation of luminescent-labelled immunometric assays for prostate-specific antigen-alpha 1-antichymotrypsin complexes in serum.
Wood WG; van der Sloot E; Böhle A
Eur J Clin Chem Clin Biochem; 1991 Dec; 29(12):787-94. PubMed ID: 1724606
[TBL] [Abstract][Full Text] [Related]
16. Generation of PSA-ACT-specific monoclonal antibodies and their application in a sandwich immunoassay.
Wang TJ; Linton HJ; Payne J; Rittenhouse HG; Chan DW; Partin AW; Wolfert RL; Kuus-Reichel K
Hybridoma; 1999 Dec; 18(6):535-41. PubMed ID: 10626683
[TBL] [Abstract][Full Text] [Related]
17. Significance of different molecular forms of serum PSA. The free, noncomplexed form of PSA versus that complexed to alpha 1-antichymotrypsin.
Lilja H
Urol Clin North Am; 1993 Nov; 20(4):681-6. PubMed ID: 7505976
[TBL] [Abstract][Full Text] [Related]
18. In vitro stability of free prostate-specific antigen (PSA) and prostate-specific antigen (PSA) complexed to alpha 1-antichymotrypsin in blood samples.
Piironen T; Pettersson K; Suonpää M; Stenman UH; Oesterling JE; Lövgren T; Lilja H
Urology; 1996 Dec; 48(6A Suppl):81-7. PubMed ID: 8973706
[TBL] [Abstract][Full Text] [Related]
19. In vivo and in vitro complex formation of prostate specific antigen with alpha 1-anti-chymotrypsin.
Huber PR; Mattarelli G; Strittmatter B; van Steenbrugge GJ; Schmid HP; Maurer A
Prostate; 1995 Sep; 27(3):166-75. PubMed ID: 7567696
[TBL] [Abstract][Full Text] [Related]
20. Reactivity of 77 antibodies to prostate-specific antigen with isoenzymes and complexes of prostate-specific antigen.
Leinonen J; Zhang WM; Paus E; Stenman UH
Tumour Biol; 1999; 20 Suppl 1():28-34. PubMed ID: 10628406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
